About BiosparQ

BiosparQ B.V. is a privately-held in vitro diagnostics company dedicated to provide healthcare professionals with a unique solution for rapid diagnostics of infectious diseases that improves patient outcomes, lowers healthcare costs and helps turn back Antimicrobial Resistance (AMR).

BiosparQ has focused its efforts on research into and the development of the Cirrus D20 medical diagnostic platform, based on proprietary DigiTOF® technology. This technology enables direct analysis of patient samples using a Single-cell MALDI-TOF approach. DigiTOF® was initially developed by the TU Delft (Prof. J. Marijnissen et.al.) in co-operation with the Dutch Contract Research Organization TNO, under contracts of the US and Dutch Ministries of Defense in the early 2000s.

After incorporation and closing of seed funding rounds in 2009, BiosparQ began as a virtual company based in Delft. In 2012, a substantial series A round was closed, which enabled BiosparQ to grow into a fully integrated company.  All DigiTOF® assets from TU Delft / TNO was acquired (Patent portfolio and Cirrus D20 prototype hard- and software). It was decided move to the Leiden Bioscience Park, renting well equipped laboratories and offices from Biopartner foundation.

In 2016 a series B funding round was closed and in 2018 the company was granted an Innovation Credit by the Dutch government, enabling the company to mature the Cirrus D20 platform and develop, validate and certify the first applications.

Since 2009, the BiosparQ established an international network of clinical partners that support the company to create the applications pipeline. Several (inter)national subsidies were granted to the BiosparQ and its partners. In 2018, a supply chain consisting of high-tech suppliers was created to prepare for production qualification.

Contact

BiosparQ B.V.
Galileïweg 8
NL-2333 BD Leiden
The Netherlands

info@biosparq.nl

https://www.biosparq.nl

News items

SMART Photonics secures €35M new funding

SMART Photonics is excited to announce a €35M Series C investment…
3 juli 2020/door Aurélie Veltema

2020 LIFE call for proposals for traditional projects – environment and resource efficiency

Please read the message on the measures relating to the COVID-19…
2 juli 2020/door Aurélie Veltema

KIEM 2020 open

Hogescholen en universitaire onderzoekers kunnen financiering…
29 juni 2020/door Aurélie Veltema

IVAM: COMPAMED Innovationsforum 2020

At the annual COMPAMED Innovation Forum, leading experts present…

Funding for projects within Open Technology Programme and Take-off

In June, the board of NWO Domain Applied and Engineering Sciences…
25 juni 2020/door Aurélie Veltema

Midden in de maak – De virtuele beurs voor de maakindustrie

"Midden in de Maak" is een nieuwe, virtuele beurs waar de Nederlandse…

New insights into the energy levels in quantum dots

(Nanowerk News) Researchers from Basel, Bochum and Copenhagen…
25 juni 2020/door Aurélie Veltema

HealthTech Innovation Days

Following its successful debut in 2019, the HealthTech Innovation…

Webinar Realiseer uw internationale ambities met DHI-subsidie

Bent u mkb'er met internationale ambities of wilt u in het buitenland…

Knowledge for growth goes digital

After carefully evaluating all possible outcomes and scenarios,…

Organ-on-chip test effect COVID-19 op het hart

Niet alleen de longen ondervinden ernstige schade door COVID-19,…
22 juni 2020/door Aurélie Veltema

RVO Webinar E-Health: Health Tech in Zuid-Afrika

Bent u actief in de digitale gezondheidszorg of e-health-toepassingen?…